Other research has found that high levels of MTDH are associated with worse outcomes and higher chances of recurrence in various cancers, including breast, bladder, colon, and hepatocellular carcinoma, underscoring its role in cancer progression and patient prognosis13,24,48,49. This evidence concerns the gene MTDH and hepatocellular carcinoma.